Formulation and evaluation of in-situ gel for otic administration of Rivastigmine for the treatment of Alzheimerś Disease. VER [Internet]. 2025 Nov. 29 [cited 2026 Mar. 18];8(15s):24-33. Available from: https://verjournal.com/index.php/ver/article/view/1113